Cas no 60717-49-9 (dimethyl[2-(piperidin-2-yl)ethyl]amine)
dimethyl[2-(piperidin-2-yl)ethyl]amine Chemical and Physical Properties
Names and Identifiers
-
- N,N-dimethyl-2-(piperidin-2-yl)ethanamine
- Dimethyl-(2-piperidin-2-yl-ethyl)-amine
- N,N-Dimethyl-2-(2-piperidinyl)-1-ethanaminedihydrochloride
- N,N-dimethyl-2-piperidin-2-ylethanamine
- dimethyl[2-(piperidin-2-yl)ethyl]amine
- 60717-49-9
- AKOS016040094
- NSC166306
- NSC-166306
- BP-11214
- 2-[2-(dimethylamino)ethyl]piperidine
- A868903
- 2-(2-Dimethylaminoethyl)piperidine
- VS-08645
- AKOS000270720
- Z336087874
- SB41121
- DA-19635
- MFCD00047329
- DTXSID60304571
- 2-(2-dimethylamino-ethyl)-piperidine
- rac.-2-(2-dimethylaminoethyl)piperidine
- VQWPLEFSACXKNE-UHFFFAOYSA-N
- rac-2-(2-(dimethylamino)ethyl)piperidine
- STK711111
- F3297-0021
- SCHEMBL4148616
- BBL028015
- CS-0206097
- EN300-122589
- ALBB-035351
-
- MDL: MFCD00047329
- Inchi: 1S/C9H20N2/c1-11(2)8-6-9-5-3-4-7-10-9/h9-10H,3-8H2,1-2H3
- InChI Key: VQWPLEFSACXKNE-UHFFFAOYSA-N
- SMILES: N1CCCCC1CCN(C)C
Computed Properties
- Exact Mass: 156.16300
- Monoisotopic Mass: 156.162648646g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 3
- Complexity: 102
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.1
- Topological Polar Surface Area: 15.3?2
Experimental Properties
- PSA: 15.27000
- LogP: 1.40900
dimethyl[2-(piperidin-2-yl)ethyl]amine Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
dimethyl[2-(piperidin-2-yl)ethyl]amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B413745-100mg |
N,N-Dimethyl-2-(2-piperidinyl)ethanamine Dihydrochloride |
60717-49-9 | 100mg |
$ 87.00 | 2023-04-18 | ||
| TRC | B413745-500mg |
N,N-Dimethyl-2-(2-piperidinyl)ethanamine Dihydrochloride |
60717-49-9 | 500mg |
$ 173.00 | 2023-04-18 | ||
| TRC | B413745-1g |
N,N-Dimethyl-2-(2-piperidinyl)ethanamine Dihydrochloride |
60717-49-9 | 1g |
$ 287.00 | 2023-04-18 | ||
| Alichem | A129006420-25g |
N,N-Dimethyl-2-(piperidin-2-yl)ethanamine |
60717-49-9 | 95% | 25g |
$421.05 | 2023-09-01 | |
| Fluorochem | 038851-1g |
2-(2-Dimethylaminoethyl)piperidine |
60717-49-9 | 95% | 1g |
£38.00 | 2022-03-01 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 020777-1g |
N,N-Dimethyl-2-(2-piperidinyl)-1-ethanaminedihydrochloride |
60717-49-9 | 1g |
632CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 051550-500mg |
N,N-Dimethyl-2-(2-piperidinyl)-1-ethanaminedihydrochloride |
60717-49-9 | 500mg |
3851CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 020777-500mg |
N,N-Dimethyl-2-(2-piperidinyl)-1-ethanaminedihydrochloride |
60717-49-9 | 500mg |
389CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 051550-2.500g |
N,N-Dimethyl-2-(2-piperidinyl)-1-ethanaminedihydrochloride |
60717-49-9 | 2.500g |
11704CNY | 2021-05-07 | ||
| Chemenu | CM377540-250mg |
dimethyl[2-(piperidin-2-yl)ethyl]amine dihydrochloride |
60717-49-9 | CM377540 | 250mg |
$61 | 2022-08-31 |
dimethyl[2-(piperidin-2-yl)ethyl]amine Suppliers
dimethyl[2-(piperidin-2-yl)ethyl]amine Related Literature
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
Additional information on dimethyl[2-(piperidin-2-yl)ethyl]amine
Dimethyl[2-(piperidin-2-yl)ethyl]amine and Its Significance in Modern Chemical Research
Dimethyl[2-(piperidin-2-yl)ethyl]amine, a compound with the CAS number 60717-49-9, represents a fascinating molecule in the realm of chemical biology and pharmaceutical research. This compound, characterized by its intricate structural framework, has garnered significant attention due to its potential applications in drug development and synthetic chemistry. The dimethyl[2-(piperidin-2-yl)ethyl]amine structure itself is a testament to the versatility of piperidine derivatives, which are widely recognized for their role in medicinal chemistry.
The CAS number 60717-49-9 serves as a unique identifier for this compound, facilitating its recognition and study within the scientific community. This numerical code ensures precision and consistency in academic and industrial settings, where accurate compound identification is paramount. The molecular composition of dimethyl[2-(piperidin-2-yl)ethyl]amine includes a piperidine ring substituted with an ethyl group, further modified by dimethyl groups. This specific arrangement imparts unique chemical properties that make it a valuable candidate for various research applications.
In recent years, the field of chemical biology has seen remarkable advancements, particularly in the development of novel therapeutic agents. Piperidine derivatives, such as dimethyl[2-(piperidin-2-yl)ethyl]amine, have been extensively studied for their ability to modulate biological pathways. The presence of the piperidine moiety enhances the compound's solubility and bioavailability, making it an attractive scaffold for drug design. Furthermore, the ethyl and dimethyl substituents contribute to its pharmacokinetic profile, influencing how it is metabolized and excreted by the body.
One of the most compelling aspects of dimethyl[2-(piperidin-2-yl)ethyl]amine is its potential role in the development of central nervous system (CNS) drugs. Piperidine derivatives are known to interact with various neurotransmitter receptors, making them promising candidates for treating neurological disorders. Current research indicates that compounds with similar structures may exhibit properties that could be beneficial in managing conditions such as depression, anxiety, and neurodegenerative diseases. The precise arrangement of atoms in dimethyl[2-(piperidin-2-yl)ethyl]amine allows it to bind effectively to these receptors, potentially leading to novel therapeutic interventions.
The synthesis of dimethyl[2-(piperidin-2-yl)ethyl]amine is another area where this compound has made significant contributions. Advanced synthetic methodologies have enabled researchers to produce this molecule with high purity and yield, facilitating its use in both laboratory studies and industrial applications. Techniques such as catalytic hydrogenation and nucleophilic substitution have been particularly effective in constructing the desired structure. These synthetic advances not only enhance the accessibility of dimethyl[2-(piperidin-2-yl)ethyl]amine but also pave the way for exploring its derivatives, which may possess even more favorable pharmacological properties.
Recent studies have also highlighted the role of dimethyl[2-(piperidin-2-yl)ethyl]amine in polymer chemistry. The compound's ability to act as a monomer or cross-linking agent has been exploited in the development of novel polymers with enhanced mechanical and thermal properties. These materials find applications in various industries, including aerospace, automotive, and electronics. The versatility of dimethyl[2-(piperidin-2-yl)ethyl]amine as a building block underscores its importance beyond traditional pharmaceutical applications.
Moreover, the environmental impact of synthesizing and utilizing dimethyl[2-(piperidin-2-yl)ethyl]amine has been a subject of interest. Researchers are increasingly focusing on green chemistry principles to minimize waste and energy consumption during production. By adopting sustainable practices, scientists aim to make the synthesis of this compound more environmentally friendly while maintaining high efficiency. Such efforts align with global initiatives to promote sustainable development in chemical manufacturing.
The future prospects of dimethyl[2-(piperidin-2-yl)ethyl]amine are vast and multifaceted. As our understanding of its chemical properties continues to grow, so does its potential for innovation across multiple disciplines. Whether it is used as a key intermediate in drug synthesis or as a precursor for advanced materials, this compound holds significant promise for addressing some of today's most pressing scientific challenges.
60717-49-9 (dimethyl[2-(piperidin-2-yl)ethyl]amine) Related Products
- 41838-46-4(1-methylpiperidin-4-amine)
- 62813-02-9(1-Cyclopropylpiperidin-4-amine)
- 73579-08-5(N,1-dimethylpiperidin-4-amine)
- 98998-25-5(8-Methyl-8-azabicyclo[3.2.1]octan-3-amine)
- 3319-01-5(1-Cyclohexylpiperidine)
- 4897-50-1(1,4'-bipiperidine)
- 87571-88-8(Endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-amine)
- 50533-97-6(N,N-Dimethylpiperidin-4-amine)
- 5004-07-9(4-(Pyrrolidinyl)piperidine)
- 127285-08-9(1-(propan-2-yl)piperidin-4-amine)